Is XPHYF or JEPQ a better dividend investment in 2026?

XPHYF currently yields 705.11% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: XPHYF offers higher current income.

What is the dividend yield difference between XPHYF and JEPQ?

XPHYF has a forward dividend yield of 705.11% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 694.01 percentage points.

Home › Compare › XPHYF vs JEPQ

XPHYF vs JEPQ: Dividend Comparison 2026

XPHYF yields 705.11% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XPHYF wins by $964927.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

XPHYF

● Live price

705.11%

Share price

$0.28

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$964927.37M

Annual income

$754,446,983,210.15

Full XPHYF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — XPHYF vs JEPQ

📍 XPHYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XPHYF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XPHYF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XPHYF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPHYF

Annual income on $10K today (after 15% tax)

$59,934.07/yr

After 10yr DRIP, annual income (after tax)

$641,279,935,728.63/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, XPHYF beats the other by $641,279,933,898.93/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPHYF + JEPQ for your $10,000?

XPHYF: 50%JEPQ: 50%

100% JEPQ50/50100% XPHYF

Portfolio after 10yr

$482463.71M

Annual income

$377,223,492,681.36/yr

Blended yield

78.19%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPHYF buys

JEPQ buys

No recent congressional trades found for XPHYF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXPHYFJEPQ

Forward yield	705.11% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$964927.37M ✓	$44.8K
Annual income after 10y	$754,446,983,210.15 ✓	$2,152.59
Total dividends collected	$947907.97M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: XPHYF vs JEPQ ($10,000, DRIP)

Year	XPHYF Portfolio	XPHYF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$81,211	$70,510.67	$11,930	$1,110.39	+$69.3K → XPHYF
2	$622,056	$535,160.68	$14,133	$1,224.34	+$607.9K → XPHYF
3	$4,496,642	$3,831,041.55	$16,632	$1,340.46	+$4.48M → XPHYF
4	$30,693,047	$25,881,640.63	$19,454	$1,457.97	+$30.67M → XPHYF
5	$197,946,383	$165,104,822.52	$22,626	$1,576.08	+$197.92M → XPHYF
6	$1,206,941,168	$995,138,538.05	$26,175	$1,694.09	+$1206.91M → XPHYF
7	$6,962,148,280	$5,670,721,230.88	$30,133	$1,811.32	+$6962.12M → XPHYF
8	$38,020,642,481	$30,571,143,821.30	$34,531	$1,927.17	+$38020.61M → XPHYF
9	$196,710,644,881	$156,028,557,426.06	$39,403	$2,041.08	+$196710.61M → XPHYF
10	$964,927,373,233	$754,446,983,210.15	$44,787	$2,152.59	+$964927.33M → XPHYF

XPHYF vs JEPQ: Complete Analysis 2026

XPHYF — Stock

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full XPHYF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this XPHYF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPHYF vs SCHD XPHYF vs JEPI XPHYF vs O XPHYF vs KO XPHYF vs MAIN XPHYF vs XYLD XPHYF vs QYLD XPHYF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.